Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer – News-Medical.Net

Kristina joined Biognosys in 2017 and held positions of increasing responsibility in Business Development focused on Biognosys next-generation proteomics services. Before joining Biognosys, Kristina gained experience in biotech evaluation and investing in her function as Principal at Nextech Invest, a Swiss-based venture capital firm focused on identifying transformative cancer medicines and investing in emerging biotechnology companies.
Kristina has a strong scientific background in immunology…

Click here to view the original article.